The Korean clinical research center for end- stage renal disease study validates the association of hemoglobin and erythropoiesis-stimulating agent dose with mortality in hemodialysis patients
- Clinical Research Center for End-Stage Renal Disease (CRC- ESRD) Investigators
- Kyungpook National University
- Clinical Research Center for End Stage Renal Disease
- Seoul National University
- Yonsei University
- The Catholic University of Korea
- Chonnam National University
- Yeungnam University
- Pusan National University
- Dong-A University
- Daegu Fatima Hospital
- Inje University
- University of Ulsan
- Gachon University
- National Health Insurance Corporation Ilsan Hospital
- Ewha Womans University
- Myongji Hospital
- Chung-Ang University
- Chungbuk National University
- Jeonbuk National University
- Chungnam National University
- Cheju Halla General Hospital
Research output: Contribution to journal › Article › peer-review
12
Scopus
citations